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Abstract
Background: Laboratory analyses of blood samples are essential for diagnostics 
and therapy monitoring of patients with bleeding and thromboembolic diseases. 
Following publication of the core curriculum for clinical thrombosis and hemosta‐
sis, the International Society on Thrombosis and Haemostasis (ISTH) recognized 
that thrombosis and hemostasis laboratory specialists require distinct competen‐
cies that differ from medical doctors working clinically with patients. To address 
this gap the ISTH formed a working group of international hemostasis and throm‐
bosis laboratory specialists to develop an evidence‐based core curriculum for labo‐
ratory specialists.
Objective: This research sought consensus from the international community on core 
competencies required for laboratory specialists in thrombosis and hemostasis.
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1  | INTRODUC TION
The International Society of Thrombosis and Haemostasis (ISTH) 
continually promotes high quality standards within the field of 
thrombosis and hemostasis through standardization and extensive 
collaboration among clinicians, researchers, and staff of diagnostic 
coagulation laboratories. With the growth and interest in this area, 
numerous regional societies have evolved to standardize practice 
within specific jurisdictions. These regional societies strive to stand‐
ardize practice within a specific jurisdiction, which include national 
regulations that may not be shared or followed by other jurisdictions. 
Furthermore, the diagnostic portfolio and specific competencies of 
a clinical coagulation laboratory reflect local requirements; medical 
laboratory practices; as well as available equipment, reagents, and 
technology.
The development and use of core curricula are an accepted means 
of defining what individuals should learn and be able to do, and have 
been successfully implemented in many countries in all fields of 
health care and scientific education and practice.1‐4 Competencies 
were felt to be the most appropriate format for defining the ISTH 
core curriculum in clinical thrombosis and hemostasis, because they 
refer to what an individual should be able to do, irrespective of how, 
when, or through what training program or experience they learned 
how to do it.5 The ISTH recognized a need and an opportunity to 
provide guidance to the international community for a continuum 
and standardization of the diagnostics in thrombosis and hemosta‐
sis. To this end, the ISTH originally undertook an initiative to draft 
and then gain consensus from the international community on a 
set of core competencies for clinical specialists taking care of pa‐
tients with disorders of thrombosis and hemostasis.5 This published 
curriculum provides an international consensus framework for the 
minimum level of knowledge required for independent practice of 
clinical specialists. The completion of this project met the stated 
2013 ISTH Council's priority for the development and application 
of core clinical competencies to ensure good standard practice and 
harmonization of training internationally.
While undertaking the clinical core curriculum project, it became 
apparent that specialists involved in laboratory diagnostic hemosta‐
sis and thrombosis require a different set of competencies from their 
clinical colleagues. It was evident that there are significant regional 
differences in diagnostic pathways, competencies, and available 
tests, and a gap in the literature in terms of defining and seeking 
international consensus on these areas. The current research seeks 
to address these shortcomings.
The use and interpretation of coagulation laboratory results are 
an integral part of the diagnosis and treatment of disorders affect‐
ing hemostasis and thrombosis and laboratory specialists provide 
Methods: A draft list of 64 competencies was developed and an online stakeholder 
survey was circulated electronically to 15 302 ISTH members and contacts in the 
wider international community. The results were analyzed and used to develop the 
final approved core curriculum.
Results: Three hundred and thirty responses contained meaningful data, with broad 
international representation of specialists. No draft competencies were excluded, 
and 58 were rated as “does” or “shows how.” The Leik measure of consensus for most 
competences was “moderate” (n = 30) or “fair” (n = 32).
Conclusions: The development of an international core curriculum for laboratory spe‐
cialists provides a foundation for the development and enhancement of education 
and quality management of the laboratory. Although there is no formal designation 
for laboratory specialists, international governing bodies and regulatory organizations 
are encouraged to consider the diagnostic core curriculum for development and ac‐
creditation of more standardized educational programs and formal assessment across 
jurisdictions.
K E Y W O R D S
competencies, curriculum, hemostasis, laboratory, thrombosis
Essentials
• To develop a global core curriculum for laboratory spe‐
cialists in thrombosis and hemostasis.
• Core competencies developed by experts from litera‐
ture and through an international survey.
• First evidence‐based framework of global core compe‐
tencies for laboratory specialists in this area.
• A reference for curriculum mapping, and educational 
and strategic development across jurisdictions.
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practitioners with clinically meaningful laboratory interpretations. 
There is, however, minimal guidance on the international training 
of the individuals producing coagulation measurements and provid‐
ing diagnostic interpretations. The European Federation of Clinical 
Chemistry and Laboratory Medicine has established a working group 
on Patient Focused Laboratory Medicine to determine a strategy 
to provide appropriate interpretative comments for all laboratory 
results to allow for patient understanding.6 The German‐speaking 
Society of Thrombosis and Haemostasis Research (GTH) 7 also es‐
tablished a permanent working group to standardize and improve 
technology and interpretation of coagulation analyses. Moreover, 
the Argentine Cooperative Group on Haemostasis and Thrombosis 
(CAHT Group)8 created a Laboratory Working Group to identify 
difficulties and needs faced by hemostasis laboratories, as well as 
discuss and agree on actions to improve performance. International 
harmonization also improves quality of laboratory diagnostics.9,10 
Strategies for selecting appropriate tests and performing state‐of‐
the‐art diagnostic procedures to include appropriate and meaningful 
interpretation of hemostasis and thrombosis laboratory results are 
essential to ensure that referring clinician and patients understand 
the results, especially as the selection of optimized diagnostic path‐
ways and reporting of laboratory results to patients will become 
more commonplace moving forward.6,11
While some medical regulatory bodies identify a limited number 
of thrombosis and hemostasis laboratory competencies for medi‐
cally trained individuals, non‐physician trained specialists are not 
regulated through the same governing bodies as physicians, thus 
minimal guidance is provided by regional and national governing 
bodies on expectations for a thrombosis and hemostasis laboratory 
specialist. Published literature is limited related to competencies in 
the area of thrombosis and hemostasis, and there is a need for col‐
laborative approaches with professional organizations, academia, 
and policy makers to build leadership and competencies within labo‐
ratory medicine, especially given the continual introduction of novel 
technologies into laboratories.12 Furthermore, rational and harmo‐
nized selection of tests and diagnostic pathways is economically 
advisable and provides opportunity to compare diagnostic outcome 
and patient care.
The aim of this project was to collect data on the international 
perspective, obtain consensus, and inform the international com‐
munity on the core competencies for a diagnostic thrombosis and 
hemostasis laboratory specialist.
2  | METHODS
This study was undertaken by the Laboratory Core Curriculum 
Working Group of the ISTH. The Working Group members (co‐au‐
thors on this paper) were invited by the ISTH Education Committee. 
The Committee reviewed recommendations of laboratory special‐
ists and chose global representatives to allow for an international 
perspective in the area of laboratory thrombosis and hemostasis. 
Members included PhDs, MDs, and laboratory technical specialists 
in the area of diagnostic thrombosis and hemostasis. A modified 
version of the methodology used in the Tuning Project (Medicine) 
was used to successfully gain consensus in the ISTH Clinical Core 
Curriculum and other previous studies.5,13,14 A review of current 
literature was undertaken, and a roundtable draft framework 
of core competencies was compiled. An electronic survey was 
drafted and distributed electronically to ISTH members using 
SurveyGizmo® (SurveyGizmo, Bolder, CO, USA). The proposal was 
discussed with the ISTH Ethics Committee, who concluded for‐
mal ethics approval for the questionnaire was not required as no 
personal identification information was collected or required to 
complete the survey.
2.1 | Literature review and synthesis
The Working Group members were asked to identify existing cur‐
ricula that encompassed laboratory testing in the area of thrombosis 
and hemostasis, which were reviewed and critiqued. The documents 
reviewed included various national guidelines and documentation 
from the Royal College of Physicians and Surgeons of Canada, the 
Royal College of Pathologists of Australasia, the Canadian Academy 
of Clinical Biochemistry, the British Society of Haematology, the 
Japanese Society for Laboratory Hematology,15‐20 as well as vari‐
ous local institutional guidelines and training programs that included 
McMaster University's (Hamilton, Canada) General Pathology, 
Pediatric Hematology and Oncology, and Medical Biochemistry fel‐
lowship programs. In addition, a PubMed search was undertaken 
using the search terms: thrombosis AND hemostasis OR haemostasis 
OR laboratory OR competencies.
2.2 | Stakeholder survey
At a face‐to‐face meeting in Berlin, Germany in July 2017, using the 
regional‐/country‐specific guidelines and brainstorming sessions, a 
draft competency framework consisting of 64 discrete competencies 
was developed. This survey was created in SurveyGizmo® and dis‐
tributed to ISTH membership and community contacts (n = 15 302) 
by e‐mail, through a collaborative member society—the International 
Society of Laboratory Hematology (ISLH)—and advertised on the 
ISTH website (www.isth.org).
Respondents were asked to indicate to what extent they consid‐
ered that each competency should have been achieved by a labo‐
ratory specialist in thrombosis and hemostasis, who had completed 
their training and was ready to practice independently in the field. 
A rating scale was developed based on Miller's triangle,21 in which 
respondents indicated:
1. Not learned—does not need to achieve this by the end of 
specialist training
2. Knows—knows about it and is able to demonstrate their under‐
standing of the appropriate basic sciences/is aware of the issues
3. Knows how—is able to explain how and why they would do this/
understands the principles
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4. Shows how—is able to demonstrate their competence in this in a 
simulated situation or artificial scenario
5. Does—is able to demonstrate mastery of this in a real situation/
does this consistently
Demographic information was also collected from respondents, in‐
cluding country of practice; type of workplace; primary area of focus; 
years in thrombosis and hemostasis field; and primary academic dis‐
cipline. This survey was open between December 2017 and January 
2018. Responses were analyzed statistically using Excel and SPSS, and 
free‐text comments were analyzed thematically.
2.3 | Statistical analysis
The Likert scores were converted from words to numbers (1‐5 as 
above) and the mean rating and standard deviation were calculated 
for each competency and for large subgroups of respondents (clini‐
cal/diagnostic lab versus other primary focus; hospital‐based ver‐
sus non‐hospital‐based; European versus non‐European; and up to 
20 years versus more than 20 years working in this field). The subset 
of respondents who answered all questions were used to compare 
the subgroup ratings using the intraclass correlation coefficient 
(ICC), to determine whether different groups rated the competen‐
cies similarly and whether any individual group could have skewed 
the overall ratings. The subset who answered all questions was also 
used to calculate the Leik measure of consensus for each compe‐
tency, to indicate the level of agreement on their rating.22
2.4 | Final analysis and framework development
Competencies were first arranged according to the mean rating of 
the Likert scores to identify whether any at the bottom should be 
omitted from the final framework, and according to the percent‐
age of “does” responses to determine the cut‐off between “does” 
and “shows how.” Finally, they were arranged according to the per‐
centage of responses which were either “does” or “shows how,” to 
determine the cut‐off between “shows how” and “knows how.” The 
Working Group reviewed each of these lists, and selected a cut‐off, 
which seemed to have face validity, with particularly careful con‐
sideration of those competencies which borderline on either side of 
these cut‐offs. The Working Group then considered the sequence of 
all the competencies and decided they should be left in the system‐
atic order in which they had been presented for the survey. Finally, 
the proposed framework and findings were reviewed and approved 
by the ISTH Council.
3  | RESULTS
3.1 | Demographics
A total of 330 surveys that contained meaningful data were received 
from around the world. An equal number of respondents (both 
n = 141) indicated they primarily worked in a clinical/diagnostic labo‐
ratory compared to those primarily working in other areas (eg re‐
search or clinical/patient care). Approximately one third (35%; n = 99 
of 283) of responders were hospital‐based. The majority of partici‐
pants had up to 20 years of experience in the field of laboratory 
thrombosis and hemostasis (n = 159), and a significant proportion 
had more than 20 years of experience (n = 122). Breakdown of the 
respondents by geographical region of practice is shown in Figure 1.
3.2 | Quantitative data analysis
The mean Likert scores for all competencies were similar across the 
large subgroups of respondents that had been identified (Table 1). 
Europeans had a slightly higher mean rating across most competen‐
cies compared to non‐Europeans, although for a single competency 
the largest difference between them was only 0.49 points on the 
Likert scale. The largest difference in mean ratings for a competency 
between those working in a clinical/diagnostic laboratory and those 
working elsewhere was 0.39; between those not based in a hospital 
and those hospital‐based was 0.37; and between those with up to 
20 years and those with more than 20 years of experience in the 
field was 0.32.
The ICC was calculated for each pairing using the subset of re‐
spondents (n = 234) who rated every single competency, Table 2. 
Values of > 0.9 indicate “strong” agreement, and 0.8‐0.89 indicate 
“high” agreement. The findings demonstrate the different subgroups 
responded similarly to the survey and no subgroup significantly 
skewed the overall ratings.
The Leik measure of consensus was also calculated for each of 
the 64 competencies using the subset of respondents who rated 
every one of them (n = 234), and is shown in Table 3. Of these, 30 
showed “moderate” consensus (Leik 0.41‐0.60), and 32 “fair” con‐
sensus (0.21‐0.40). Two showed “poor” consensus (≤0.20), which 
were “Use baseline laboratory tests including full/complete blood 
count (FBC/CBC), platelet count (PC), blood film, prothrombin 
F I G U R E  1   Breakdown of survey respondents by region (all 330 
responses)
Europe
46%
Asia
8%
Africa
7%
Oceania
4%
North America
16%
Latin America 
& Caribbean
15%
Middle East
4%
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time (PT), activated partial prothrombin time (APTT), fibrinogen, 
and thrombin time (TT) to screen for coagulation disorders” and 
“Explain screening test results and advise on further testing if 
appropriate.”
The mean ratings of each competency, together with a visual rep‐
resentation of responses, are shown in Table 3. The Working Group 
reviewed the list of competencies ranked by percentage of respon‐
dents who indicated “does” and agreed that a cut‐off value at or above 
51.9% had face validity to support a “does” competency in the pro‐
posed framework. Reviewing the competencies ranked by percent‐
age of respondents who indicated either “does” or “shows how,” led 
the Working Group to suggest that a cut‐off of less than 61.1% had 
face validity as a “knows how” competency in the proposed frame‐
work. The remaining competencies were placed in the “shows how” 
category. The Working Group reviewed the borderline competencies 
at each of these cut‐off points and agreed that none needed to be 
moved to a different category. Based on the analysis of survey data, 
the Working Group proposed that laboratory specialists in thrombo‐
sis and hemostasis who had completed their training should be able 
to do 26 of the competencies, show how to do 32 of the competencies, 
and know how to do the remaining 6 competencies (Table 3).
3.3 | Qualitative data analysis
The free‐text responses were supportive of the survey and devel‐
opment of a core curriculum, and many commented that it seemed 
comprehensive. The Working Group reviewed all suggestions for 
additional competencies but agreed that the majority were already 
represented in the framework (eg differentiating types of throm‐
bocytopenia, interpreting results in consumptive coagulopathy, 
the special situations of HIV and malnutrition, teaching compe‐
tencies, and multidisciplinary team‐working). Other suggestions 
seemed more appropriate for medical doctors rather than labo‐
ratory specialists (eg gene therapy, communication with patients, 
and the use of clinical probability scoring systems such as BATS—
bleeding assessment tools). The Working Group agreed that 
adding a competency relating to the measurement of extended 
half‐life products was appropriate, specifically, the laboratory 
specialist should be able to “Apply understanding of assays used 
for the measurement of extended half‐life products” at the level of 
shows how. The Working Group noted that as of yet these products 
are not available internationally.
One response suggested rewording the Section 6 competency, 
“Perform functional and genetic testing of congenital and acquired 
prothrombotic factors (e.g., FV Leiden, Prothrombin G20210A, 
JAK2)” because there is currently no standardized hypercoagula‐
tion work‐up to include these genetic tests. The Working Group 
supports this comment and therefore decided to add, “in collabora‐
tion with the medical service if clinically indicated” at the end of the 
competency.
Respondents also highlighted the importance of clarifying how 
this curriculum for laboratory specialists relates to, and differs from, 
the ISTH Clinical Curriculum; that some individuals work across the 
field and so need both clinical and laboratory competencies; and that 
laboratory specialists also need to be able to follow regional require‐
ments and respond to local variation. It is also recognized that there 
may be variability in available thrombosis and hemostasis laboratory 
services and laboratory specialists’ ability to meet the core curricu‐
lum in relation to local requirements and practices.
TA B L E  2   Comparison of rating of competencies between 
subgroups (234 complete responses)
Comparison of ratings of individual 
subgroups
Intraclass correlation 
coefficient – absolute 
agreement (95% CI)
Clinical/diagnostic lab vs other 
primary focus
0.88 (0.21‐0.96) = “High” 
agreement
Hospital‐based vs 
non‐hospital‐based
0.91 (0.83‐0.95) = “Strong” 
agreement
European vs non‐European 0.80 (0.16‐0.94) = “High” 
agreement
Up to 20 years vs more than 20 years 
in field
0.97 (0.94‐0.98) = “Strong” 
agreement
Abbreviation: CI, confidence interval.
Group
Number of 
respondents
Combined means and 
(SD) of all item ratings
Minimum‐maximum 
of item mean ratings
All 330 4.11 (1.07) 3.27‐4.58
Clinical/diagnostic lab 141 4.19 (0.31) 3.32‐4.69
Primary focus not 
 clinical/diagnostic lab
141 4.05 (0.25) 3.25‐4.61
Hospital‐based 99 4.12 (0.32) 3.28‐4.68
Not hospital‐based 184 4.12 (0.26) 3.22‐4.60
European 116 4.23 (0.31) 3.34‐4.81
Non‐European 137 4.06 (0.26) 3.21‐4.52
0‐20 years in field 159 4.07 (0.27) 3.25‐4.58
>20 years in field 122 4.18 (0.28) 3.34‐4.69
Abbreviation: SD, standard deviation.
TA B L E  1   Mean response score for all 
respondents and individual subgroups 
(all 330 respondents, note some did not 
respond to every question)
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4  | DISCUSSION
The ISTH undertook this project to help address an identified gap 
in published guidance on core competencies for a thrombosis and 
hemostasis laboratory specialist for the international community. 
The aim was to develop a consensus‐based core curriculum that all 
independent, expert clinical and non‐clinical laboratory specialists in 
the area of hemostasis and thrombosis would be expected to dem‐
onstrate. In addition, it was anticipated that such a curriculum could 
be used as a blueprint for training programs, and would be a useful 
resource for international governing bodies and regulatory organiza‐
tions to help guide expectations in areas of laboratory thrombosis 
and hemostasis.
This study used the same methodology as the ISTH clinical core 
curriculum in thrombosis and hemostasis,5 but this time with a care‐
fully selected group of thrombosis and hemostasis laboratory spe‐
cialists instead of clinicians.
Specialists are required in all areas of laboratory medicine. This 
is, at least in part, due to the gap in the availability of specific ob‐
jectives in clinical training programs and the continual technical ad‐
vances in instrumentation, as well as an industry move to develop 
manufacturer‐specific diagnostic test algorithms, and acknowl‐
edgment of the lack of technical laboratory specialists across dis‐
ciplines. Laboratory thrombosis and hemostasis is an area that is 
highly specialized for the investigation of coagulopathies, including 
the selection and interpretation of laboratory tests and possibly ad‐
vising on further testing, as this is often complex, diverse, and very 
patient‐specific.
4.1 | Limitations of the research
The results from the survey generated 330 meaningful responses, 
with 234 (70.9%) complete responses, representing a very low re‐
sponse rate. “Survey fatigue” and the length of the survey may have 
been factors influencing the completion rate. The majority of re‐
sponses (62%) were from Europe (46%) and North America (16%), 
but the wider international community was represented in this 
study and no national or other large subgroup statistically skewed 
the overall findings. The survey was only available in English, which 
may have had a negative impact on the response rate, and even 
perhaps the reason for some of the incomplete surveys, but it did 
avoid issues of changes in meaning of competencies that can some‐
times arise when they are translated. It is unclear why almost 30% 
of respondents who started the survey did not rate all competen‐
cies; however, the number received did allow for valid cohort and 
subgroup analysis (n = 330), as well as ICC and Leik calculations 
(n = 234).
4.2 | Validity of survey results
There is recognition in the international community of the complex‐
ity and diversity in the area of laboratory hemostasis and thrombosis 
as respondents scored all 64 competencies as “does,” “shows how,” or 
“knows how.” As a diverse group of international diagnostic experts 
in this area developed the competencies, and no unimportant “dis‐
tractors” were included, it was not unreasonable to expect that the 
criteria were also likely to be considered important by the survey 
participants. Further evidence of the face validity of the draft com‐
petencies was that the responses only demonstrated “poor” consen‐
sus for two competencies, with the other 62 competencies showing 
moderate (n = 30) or fair (n = 32) consensus as determined by the 
approach described by Leik.22
4.3 | The implications and 
applications of the findings
Laboratory medicine has an important role in the diagnosis and man‐
agement of patients. The core curriculum for a laboratory specialist 
in thrombosis and hemostasis provides an international perspec‐
tive and framework in this field for clinical laboratories that provide 
specialized laboratory services in this area. This core curriculum is 
offered as a focus for education, training, and accreditation to pro‐
mote a quality laboratory medicine service through consultation and 
interpretation of diagnostic laboratory test results in the area of he‐
mostasis and thrombosis.
4.4 | Areas of future work
The core curriculum provides ISTH and Scientific Subcommittees 
with a framework for the development of educational tools and 
resources for members interested in specializing in laboratory he‐
mostasis and thrombosis. While there are currently no regulatory 
guidelines in this area, the development of the core curriculum 
will provide many countries with guidance that could potentially 
be used for accreditation purposes. ISTH will be able to monitor 
the uptake of the curriculum over time with the development of 
future education training projects through the ISTH Education 
and Outreach Committee. The ISTH also recognizes that periodic 
review of this and the clinical core curriculum by hemostasis and 
thrombosis expert panels will be required, eg every 5 years, as ad‐
vancements in this laboratory and clinical subspecialty continue 
to evolve.
5  | CONCLUSION
The draft ISTH core curriculum for laboratory specialists in hemo‐
stasis and thrombosis was accepted by the international commu‐
nity, as evidenced by the level of agreement and rating across all 
64 competencies and positive free‐text comments. Although there 
is no formal designation for thrombosis and hemostasis laboratory 
specialists, international governing bodies and regulatory organiza‐
tions now have a consensus‐based international core curriculum that 
will allow for the mapping, development, and accreditation of edu‐
cational programs and formal assessment of laboratory specialists 
across jurisdictions.
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